DV
Dividend Vision

CNTA — Centessa Pharmaceuticals plc

No longer trading. This fund has been liquidated; the figures below are frozen at its final trading day.

Centessa Pharmaceuticals plc (CNTA)

CNTA is a healthcare equity stock that trades as a publicly listed company rather than a traditional ETF structure. As a biopharmaceutical company, it does not have a defined investment strategy, underlying basket of assets, or distribution characteristics typical of ETFs. The absence of a yield profile, distribution frequency, and expense ratio reflects its nature as an individual stock rather than a fund product, making it unsuitable for analysis within a dividend ETF platform context. Trading ceased after 06/24/2026; the shares last closed at $40.50. No later quote reflects a live market.

CNTA key facts

Asset type
Stock
Asset class
Equity
Inception date
05/28/2021
Distribution frequency
None
Last close
$40.50
Market cap
$6,266,618,368
Average volume
1895826.0
Beta
1.121
Payout ratio
0.0
Forward P/E
-22.7528
EPS
$-1.78